王秋雁

摘要：目的 观察临床在对反流性食管炎患者进行治疗的过程中使用埃索美拉唑联合莫沙必利进行治疗的效果。方法 研究所纳入患者为50例，为本院在2020年2月至12月所接诊，结合盲选法取纳入样本病例中的25例患者，以常规方式进行治疗，即对照组，余下患者在治疗中则运用埃索美拉唑联合莫沙必利展开治疗，即观察组。分析两组患者的恢复情况。结果 结合对两组患者整体恢复情况，病症缓解用时对比，观察组均具备优势，P<0.05。结合统计可知，在恢复过程中，观察组仅1例患者出现并发症，而对照组则有6例患者出现并发症，P<0.05。结论  在对反流性食管炎患者进行治疗的过程中按照埃索美拉唑联合莫沙必利进行治疗，可以有效保障对该部分患者的治疗效果，促进患者恢复。

Abstract： Objective To observe the clinical effect of esomeprazole combined with moxapride in the treatment of patients with reflux esophagitis. Methods A total of 50 patients were enrolled in this study， who were admitted to our hospital from February to December 2020. Twenty-five of the included patients were selected by blind selection method and received conventional treatment， i.e. the control group， while the remaining patients were treated with esomeprazole combined with moxapril， i.e. the observation group. The recovery of patients in the two groups was analyzed. Results Combined with the comparison of the overall recovery of patients in the two groups and the time taken for disease remission， the observation group had advantages （P<0.05）. Combined with statistics， in the process of recovery， only 1 patient in the observation group had complications， while 6 patients in the control group had complications， P < 0.05.  Conclusion In the treatment of patients with reflux esophagitis， the combination of esomeprazole and moxapride can effectively guarantee the treatment effect of these patients and promote the recovery of patients.

關键词：埃索美拉唑;莫沙必利;反流性食管炎;临床疗效

消化系统病症在临床一直保持有较高的发生率，其中反流性食管炎属于接诊量较高的类型，在各个年龄段均保持有较高的发生率[1]。反流性食管炎是指胃部、十二指肠内容物反流进入食管引起的食管炎症性病变，患者患病后临床症状表现为胃脘部不适、咳嗽、胸痛等，对患者健康所造成的影响较大[2]。现目前，临床针对反流性食管炎主要给予抑酸药物和促胃动力药物治疗，以控制病情发展[3]。诱发该症的因素存在于多个层面，为促使该部分患者可以尽快得到恢复，更需要采取有效的治疗措施。本次研究就针对埃索美拉唑联合莫沙必利在治疗该症中的作用进行分析，效果满意，具体如下。……